Algernon Announces Pricing of Prospectus Offering
September 06, 2019 07:00 ET
|
Algernon Pharmaceuticals
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc....
Algernon Retains Renmark Financial Communications
March 12, 2019 23:46 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, March 12, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...